[121] Parsons DW, Jones S, Zhang X, Lin JCH, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM,
Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA,
Tekleab H, Diaz LA, Hartigan J, Smith DR, Strausberg RL, Marie SKN, Shinjo SMO, Yan H,
Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE,
Kinzler KW.
An integrated genomic analysis of human glioblastoma multiforme.
Science 321;
1807–1812 Sep 2008. PMC2820389.
[122] Barber TD, McManus K, Yuen KWY, Reis M, Parmigiani G, Shen D, Barrett I, Nouhi Y, Spencer
F, Markowitz S, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C, Hieter P.
Chromatid
cohesion defects may underlie chromosome instability in human colorectal cancers.
Proc Natl
Acad Sci U S A 105; 3443–3448 Mar 2008. PMC2265152.
[123] Schaeffer EM, Marchionni L, Huang Z, Simons B, Blackman A, Yu W, Parmigiani G, Berman DM.
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and
are reactivated in cancer.
Oncogene 27; 7180–7191 Dec 2008. PMC2676849.
[124] Dominici F, Wang C, Crainiceanu C, Parmigiani G.
Model selection and health effect estimation
in environmental epidemiology.
Epidemiology 19; 558–560 Jul 2008.
[125] Venturini S, Dominici F, Parmigiani G.
Gamma shape mixtures for heavy-tailed distributions
. Ann
Appl Stat 2; 756–776 2008.
[126] Parmigiani G, Chen S, Velculescu V.
TRAB: testing whether mutation frequencies are above an
unknown background.
Stat Appl Genet Mol Biol 7; Article11 2008.
[127] Tai YC, Chen S, Parmigiani G, Klein AP.
Incorporating tumor immunohistochemical markers in
BRCA1 and BRCA2 carrier prediction.
Breast Cancer Res 10; 401 2008. PMC2397515.
[128] Crainiceanu C, Dominici F, Parmigiani G.
Adjustment uncertainty in effect estimation
. Biometrika
95; 635–651 2008.
[129] Katki HA, Blackford A, Chen S, Parmigiani G.
Multiple diseases in carrier probability estimation:
accounting for surviving all cancers other than breast and ovary in BRCAPRO.
Stat Med 27;
4532–4548 Sep 2008. PMC2562929.
[130] Pattaro C, Ruczinski I, Fallin DM, Parmigiani G.
Haplotype block partitioning as a tool for
dimensionality reduction in snp association studies.
BMC Genomics 9; 405 2008. PMC2547855.
[131] Yang Z, Stratton C, Francis PJ, Kleinman ME, Tan PL, Gibbs D, Tong Z, Chen H, Constantine
R, Yang X, Chen Y, Zeng J, Davey L, Ma X, Hau VS, Wang C, Harmon J, Buehler J, Pearson
E, Patel S, Kaminoh Y, Watkins S, Luo L, Zabriskie NA, Bernstein PS, Cho W, Schwager A,
Hinton DR, Klein ML, Hamon SC, Simmons E, Yu B, Campochiaro B, Sunness JS, Campochiaro
P, Jorde L, Parmigiani G, Zack DJ, Katsanis N, Ambati J, Zhang K.
Toll-like receptor 3 and
geographic atrophy in age-related macular degeneration.
N Engl J Med 359; 1456–1463 Oct
2008. PMC2573951.
[132] Leary RJ, Lin JC, Cummins J, Boca S, Wood LD, Parsons DW, Jones S, Sjblom T, Park BH, Par-
sons R, Willis J, Dawson D, Willson JKV, Nikolskaya T, Nikolsky Y, Kopelovich L, Papadopoulos
N, Pennacchio LA, Wang TL, Markowitz SD, Parmigiani G, Kinzler KW, Vogelstein B, Vel-
culescu VE.
Integrated analysis of homozygous deletions, focal amplifications, and sequence
alterations in breast and colorectal cancers.
Proc Natl Acad Sci U S A 105; 16224–16229 Oct
2008. PMC2571022.
13
[133] Iversen Jr ES, Parmigiani G, Chen S.
Multiple model evaluation absent the gold standard:
BRCA1/2 mutation carrier probability models
. Journal of the American Statistical Association
103(483); 897–909. 2008.
[134] Kortenhorst MSQ, Zahurak M, Shabbeer S, Kachhap S, Galloway N, Parmigiani G, Verheul HMW,
Carducci MA.
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines
with variable sensitivity to histone deacetylase inhibitors.
Clin Cancer Res 14; 6886–6894 Nov
2008. PMC2603330.
[135] Braun R, Cope L, Parmigiani G.
Identifying differential correlation in gene/pathway combinations.
BMC Bioinformatics 9; 488 Nov 2008. PMC2613418.
[136] Parmigiani G, Boca S, Lin J, Kinzler KW, Velculescu V, Vogelstein B.
Design and analysis issues in
genome-wide somatic mutation studies of cancer.
Genomics 93; 17–21 Jan 2009. PMC2820387.
[137] Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JCH, Palmisano E,
Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE,
Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP.
Exomic sequencing identifies palb2
as a pancreatic cancer susceptibility gene.
Science 324(5924); 217 Mar 2009. PMC2684332.
[138] Blackford A, Parmigiani G, Kensler TW, Wolfgang C, Jones S, Zhang X, Parsons DW, Lin JCH,
Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Klein A,
Cameron JL, Olino K, Schulick R, Winter J, Vogelstein B, Velculescu VE, Kinzler KW, Hruban
RH.
Genetic mutations associated with cigarette smoking in pancreatic cancer.
Cancer Res 69;
3681–3688 Apr 2009. PMC2669837.
[139] Chen S, Blackford AL, Parmigiani G.
Tailoring BRCAPRO to Asian-Americans.
J Clin Oncol 27;
642–3; author reply 643–4 Feb 2009.
[140] Lin X, Asfari B, Marchionni L, Cope L, Parmigiani G, Naiman D, Geman D.
The ordering of
expression among a few genes can provide simple cancer biomarkers and signal brca1 mutations
.
BMC Bioinformatics 10; 256 2009. PMC2745389.
[141] Zhou XK, Clyde MA, Garrett J, Lourdes V, O’Connell M, Parmigiani G, Turner DJ, Wiles T.
Statistical methods for automated drug susceptibility testing: Bayesian minimum inhibitory con-
centration prediction from growth curves. Annals of Applied Statistics 2009,; Vol.3,No.2,710–730
Aug 2009.
[142] Favorova OO, Favorov AV, Boiko AN, Sudomoina MA, Andreevskii TV, Alekseenkov AD, Kulakova
OG, Gusev EI, Parmigiani G, Ochs MF. Genetic predisposition to multiple sclerosis as a polygenic
autoimmune disease. Zh Nevrol Psikhiatr Im S S Korsakova 109; 16–22 2009.
[143] Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani
G, Dorsch M, Peacock CD, Watkins DN.
A primary xenograft model of small-cell lung cancer
reveals irreversible changes in gene expression imposed by culture in vitro.
Cancer Res 69; 3364–
3373 Apr 2009.
[144] He X, Marchionni L, Hansel DE, Yu W, Sood A, Yang J, Parmigiani G, Matsui W, Berman DM.
Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma.
Stem Cells
27; 1487–1495 Jul 2009.
14